{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:27:17Z","timestamp":1787689637825,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100022831","name":"Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","doi-asserted-by":"publisher","award":["2023\/ 054."],"award-info":[{"award-number":["2023\/ 054."]}],"id":[{"id":"10.13039\/100022831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"DOI":"10.1007\/s11126-025-10241-8","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:23:44Z","timestamp":1763367824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kynurenine Pathway Metabolites and Executive Function Impairments in Generalized Anxiety Disorder: A Case Control Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4608-0387","authenticated-orcid":false,"given":"Defne Flora","family":"G\u00f6y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-4971","authenticated-orcid":false,"given":"Filiz","family":"Kulacaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9991-3939","authenticated-orcid":false,"given":"Ali","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-1710","authenticated-orcid":false,"given":"Hacer Eroglu","family":"Icli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ahmad","family":"Bik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"10241_CR1","first-page":"1","volume":"378","author":"EP Terlizzi","year":"2020","unstructured":"Terlizzi EP, Villarroel MA. Symptoms of generalized anxiety disorder among adults: United States, 2019. NCHS Data Brief. 2020;378:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"10241_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1502514","author":"MB Stein","year":"2015","unstructured":"Stein MB, Sareen J. CLINICAL PRACTICE. Generalized anxiety disorder. N Engl J Med. 2015. https:\/\/doi.org\/10.1056\/NEJMcp1502514.","journal-title":"N Engl J Med"},{"key":"10241_CR3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-050212-185544","author":"MG Newman","year":"2013","unstructured":"Newman MG, Llera SJ, Erickson TM, Przeworski A, Castonguay LG. Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment. Annu Rev Clin Psychol. 2013. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050212-185544.","journal-title":"Annu Rev Clin Psychol"},{"key":"10241_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.05.036","author":"M Furtado","year":"2015","unstructured":"Furtado M, Katzman MA. Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res. 2015. https:\/\/doi.org\/10.1016\/j.psychres.2015.05.036.","journal-title":"Psychiatry Res"},{"key":"10241_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.27","author":"N Vogelzangs","year":"2013","unstructured":"Vogelzangs N, Beekman ATF, De Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013. https:\/\/doi.org\/10.1038\/tp.2013.27.","journal-title":"Transl Psychiatry"},{"key":"10241_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186546","author":"E Won","year":"2020","unstructured":"Won E, Kim YK. Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186546.","journal-title":"Int J Mol Sci"},{"key":"10241_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.146","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017. https:\/\/doi.org\/10.1038\/npp.2016.146.","journal-title":"Neuropsychopharmacology"},{"key":"10241_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070734","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, T\u00f3th F, Poly\u00e1k H, Szab\u00f3 \u00c1, M\u00e1ndi Y, V\u00e9csei L. Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9070734.","journal-title":"Biomedicines"},{"key":"10241_CR9","doi-asserted-by":"publisher","DOI":"10.33588\/rn.6902.2018371","author":"R Langarita-Llorente","year":"2019","unstructured":"Langarita-Llorente R, Gracia-Garc\u00eda P. Neuropsychology of generalized anxiety disorders: a systematic review. Rev Neurol. 2019. https:\/\/doi.org\/10.33588\/rn.6902.2018371.","journal-title":"Rev Neurol"},{"key":"10241_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.09.072","author":"BJA Gulpers","year":"2022","unstructured":"Gulpers BJA, Verhey FRJ, Eussen SJPM, Schram MT, de Galan BE, van Boxtel MPJ, et al. Anxiety and cognitive functioning in the Maastricht study: a cross-sectional population study. J Affect Disord. 2022. https:\/\/doi.org\/10.1016\/j.jad.2022.09.072.","journal-title":"J Affect Disord"},{"key":"10241_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2016.05.015","author":"B Gulpers","year":"2016","unstructured":"Gulpers B, Ramakers I, Hamel R, K\u00f6hler S, Oude Voshaar R, Verhey F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016. https:\/\/doi.org\/10.1016\/j.jagp.2016.05.015.","journal-title":"Am J Geriatr Psychiatry"},{"key":"10241_CR12","doi-asserted-by":"publisher","DOI":"10.1159\/000496623","author":"L Harber","year":"2019","unstructured":"Harber L, Hamidian R, Bani-Fatemi A, Wang KZ, Dada O, Messina G, et al. Meta-analysis of neuropsychological studies in panic disorder patients: evidence of impaired performance during the emotional Stroop task. Neuropsychobiology. 2019. https:\/\/doi.org\/10.1159\/000496623.","journal-title":"Neuropsychobiology"},{"key":"10241_CR13","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2014.997288","author":"MS O\u2019Toole","year":"2015","unstructured":"O\u2019Toole MS, Pedersen AD, Hougaard E, Rosenberg NK. Neuropsychological test performance in social anxiety disorder. Nord J Psychiatry. 2015. https:\/\/doi.org\/10.3109\/08039488.2014.997288.","journal-title":"Nord J Psychiatry"},{"key":"10241_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073642","author":"AI Rosa-Alc\u00e1zar","year":"2021","unstructured":"Rosa-Alc\u00e1zar AI, Rosa-Alc\u00e1zar \u00c1, Mart\u00ednez-Esparza IC, Storch EA, Olivares-Olivares PJ. Response inhibition, cognitive flexibility and working memory in obsessive-compulsive disorder, generalized anxiety disorder and social anxiety disorder. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18073642.","journal-title":"Int J Environ Res Public Health"},{"key":"10241_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.09.132","author":"SL Warren","year":"2021","unstructured":"Warren SL, Heller W, Miller GA. The structure of executive dysfunction in depression and anxiety. J Affect Disord. 2021. https:\/\/doi.org\/10.1016\/j.jad.2020.09.132.","journal-title":"J Affect Disord"},{"key":"10241_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2019.101754","author":"R Shi","year":"2019","unstructured":"Shi R, Sharpe L, Abbott M. A meta-analysis of the relationship between anxiety and attentional control. Clin Psychol Rev. 2019. https:\/\/doi.org\/10.1016\/j.cpr.2019.101754.","journal-title":"Clin Psychol Rev"},{"key":"10241_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12814","author":"S van den Ameele","year":"2020","unstructured":"van den Ameele S, van Nuijs ALN, Lai FY, Schuermans J, Verkerk R, van Diermen L, et al. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder. Bipolar Disord. 2020. https:\/\/doi.org\/10.1111\/bdi.12814.","journal-title":"Bipolar Disord"},{"key":"10241_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-022-02513-5","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Spekker E, Szab\u00f3 \u00c1, Poly\u00e1k H, V\u00e9csei L. Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents\u2014in celebration of 80th birthday of professor Peter riederer. J Neural Transm. 2022. https:\/\/doi.org\/10.1007\/s00702-022-02513-5.","journal-title":"J Neural Transm"},{"key":"10241_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2016_5","author":"EY Bryleva","year":"2017","unstructured":"Bryleva EY, Brundin L. Suicidality and activation of the kynurenine pathway of tryptophan metabolism. Curr Top Behav Neurosci. 2017. https:\/\/doi.org\/10.1007\/7854_2016_5.","journal-title":"Curr Top Behav Neurosci"},{"key":"10241_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0414-4","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-019-0414-4.","journal-title":"Mol Psychiatry"},{"key":"10241_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172699","author":"A Birner","year":"2017","unstructured":"Birner A, Platzer M, Bengesser SA, Dalkner N, Fellendorf FT, Queissner R, et al. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder. PLoS One. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0172699.","journal-title":"PLoS One"},{"key":"10241_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.05.020","author":"S Erhardt","year":"2017","unstructured":"Erhardt S, Schwieler L, Imbeault S, Engberg G. The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology. 2017. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.020.","journal-title":"Neuropharmacology"},{"key":"10241_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2017.04.015","author":"M Platzer","year":"2017","unstructured":"Platzer M, Dalkner N, Fellendorf FT, Birner A, Bengesser SA, Queissner R, et al. Tryptophan breakdown and cognition in bipolar disorder. Psychoneuroendocrinology. 2017. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.04.015.","journal-title":"Psychoneuroendocrinology"},{"key":"10241_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.03.002","author":"DC Maddison","year":"2015","unstructured":"Maddison DC, Giorgini F. The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol. 2015. https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002.","journal-title":"Semin Cell Dev Biol"},{"key":"10241_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.02.005","author":"J Ahlberg Weidenfors","year":"2025","unstructured":"Ahlberg Weidenfors J, Gri\u0161ka V, Li X, Pranckevi\u010dien\u0117 A, Pakalnien\u0117 J, Atlas A, et al. Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis. Brain Behav Immun. 2025. https:\/\/doi.org\/10.1016\/j.bbi.2025.02.005.","journal-title":"Brain Behav Immun"},{"key":"10241_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149415","author":"M Kupjetz","year":"2025","unstructured":"Kupjetz M, Wences Chirino TY, Joisten N, Zimmer P. Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: implications for multiple sclerosis. Brain Res. 2025. https:\/\/doi.org\/10.1016\/j.brainres.2024.149415.","journal-title":"Brain Res"},{"key":"10241_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.10.020","author":"MI Butler","year":"2022","unstructured":"Butler MI, Long-Smith C, Moloney GM, Morkl S, O\u2019Mahony SM, Cryan JF, et al. The immune-kynurenine pathway in social anxiety disorder. Brain Behav Immun. 2022. https:\/\/doi.org\/10.1016\/j.bbi.2021.10.020.","journal-title":"Brain Behav Immun"},{"key":"10241_CR28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington (DC): American Psychiatric Publishing; 2013.","edition":"5"},{"key":"10241_CR29","doi-asserted-by":"publisher","unstructured":"First MB. The encyclopedia of clinical psychology. Columbia univ dep psychiatry N Y state psychiatr Inst. 2015; https:\/\/doi.org\/10.1002\/9781118625392.wbecp427","DOI":"10.1002\/9781118625392.wbecp427"},{"key":"10241_CR30","doi-asserted-by":"publisher","DOI":"10.5080\/u23431","author":"M Elbir","year":"2019","unstructured":"Elbir M, Alp Topbas O, Bayad S, Kocabas T, Topak OZ, Cetin S, et al. Adaptation and reliability of the structured clinical interview for DSM-5 disorders \u2013 Clinician version (SCID-5\/CV) to the Turkish Language. Compr Psychiatry. 2019. https:\/\/doi.org\/10.5080\/u23431.","journal-title":"Compr Psychiatry"},{"key":"10241_CR31","volume-title":"The State-Trait anxiety inventory: test manual","author":"CD Spielberger","year":"1970","unstructured":"Spielberger CD. The State-Trait anxiety inventory: test manual. Palo Alto, CA: Consulting Psychologist; 1970."},{"key":"10241_CR32","volume-title":"Concurrent validity and reliability of the State-Trait anxiety inventory in Turkish population","author":"N \u00d6ner","year":"1983","unstructured":"\u00d6ner N, Le Compte A. Concurrent validity and reliability of the State-Trait anxiety inventory in Turkish population. Istanbul: Bogazici University; 1983."},{"key":"10241_CR33","volume-title":"Wisconsin card sorting test manual: revised and expanded","author":"RK Heaton","year":"1993","unstructured":"Heaton RK, Chelune CJ, Talley JL, Kay GG, Curtiss G. Wisconsin card sorting test manual: revised and expanded. Odessa (FL): Psychological Assessment Resources; 1993."},{"key":"10241_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2011.568525","author":"JP Steinmetz","year":"2011","unstructured":"Steinmetz JP, Houssemand C. What about inhibition in the Wisconsin card sorting test? Clin Neuropsychol. 2011. https:\/\/doi.org\/10.1080\/13854046.2011.568525.","journal-title":"Clin Neuropsychol"},{"key":"10241_CR35","volume-title":"Neuropsychological Assessment","author":"MD Lezak","year":"1995","unstructured":"Lezak MD. Neuropsychological Assessment. USA: Oxford University Press; 1995."},{"key":"10241_CR36","doi-asserted-by":"publisher","DOI":"10.1037\/pas0001015","author":"S \u00c7elik","year":"2021","unstructured":"\u00c7elik S, O\u011fuz M, Konur U, K\u00f6kt\u00fcrk F, Atasoy N. Comparison of computerized and manual versions of the Wisconsin card sorting test on schizophrenia and healthy samples. Psychol Assess. 2021. https:\/\/doi.org\/10.1037\/pas0001015.","journal-title":"Psychol Assess"},{"key":"10241_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/S1364-6613(00)01538-2","author":"A Baddeley","year":"2000","unstructured":"Baddeley A. The episodic buffer: a new component of working memory? Trends Cogn Sci. 2000. https:\/\/doi.org\/10.1016\/S1364-6613(00)01538-2.","journal-title":"Trends Cogn Sci"},{"key":"10241_CR38","doi-asserted-by":"publisher","DOI":"10.3758\/BF03196772","author":"ARA Conway","year":"2005","unstructured":"Conway ARA, Kane MJ, Bunting MF, Hambrick DZ, Wilhelm O, Engle RW. Working memory span tasks: a methodological review and user\u2019s guide. Psychon Bull Rev. 2005. https:\/\/doi.org\/10.3758\/BF03196772.","journal-title":"Psychon Bull Rev"},{"key":"10241_CR39","doi-asserted-by":"publisher","DOI":"10.1006\/cogp.1999.0734","author":"A Miyake","year":"2000","unstructured":"Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex frontal lobe tasks: a latent variable analysis. Cognit Psychol. 2000. https:\/\/doi.org\/10.1006\/cogp.1999.0734.","journal-title":"Cognit Psychol"},{"key":"10241_CR40","doi-asserted-by":"publisher","DOI":"10.1076\/1380-3395(200008)22:4;1-0;FT518","author":"K Arbuthnott","year":"2000","unstructured":"Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000. https:\/\/doi.org\/10.1076\/1380-3395(200008)22:4;1-0;FT518.","journal-title":"J Clin Exp Neuropsychol"},{"key":"10241_CR41","doi-asserted-by":"publisher","DOI":"10.1037\/h0054651","author":"JR Stroop","year":"1935","unstructured":"Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935. https:\/\/doi.org\/10.1037\/h0054651.","journal-title":"J Exp Psychol"},{"key":"10241_CR42","first-page":"75","volume":"2","author":"S Karaka\u015f","year":"1999","unstructured":"Karaka\u015f S, Erdo\u011fan E, Sak L, Soysal A\u015e, Ulusoy T, Ulusoy \u0130Y, et al. Stroop test TBAG form: standardization for the Turkish culture, reliability and validity. Klin Psikiyatri. 1999;2:75\u201388.","journal-title":"Klin Psikiyatri"},{"key":"10241_CR43","volume-title":"15th National neurology Congress","author":"A Bing\u00f6l","year":"1994","unstructured":"Bing\u00f6l A, Ergene G. Verbal fluency skills in Turkish population: a standardization study. 15th National neurology Congress. Turkey: Adana; 1994."},{"key":"10241_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.05.018","author":"SJ Brown","year":"2021","unstructured":"Brown SJ, Huang XF, Newell KA. The kynurenine pathway in major depression: what we know and where to next. Neurosci Biobehav Rev. 2021. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.05.018.","journal-title":"Neurosci Biobehav Rev"},{"key":"10241_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/1073191115602552","author":"J Llin\u00e0s-Regl\u00e0","year":"2017","unstructured":"Llin\u00e0s-Regl\u00e0 J, Vilalta-Franch J, L\u00f3pez-Pousa S, Calv\u00f3-Perxas L, Torrents Rodas D, Garre-Olmo J. The trail making test: association with other neuropsychological measures and normative values for adults aged 55 years and older from a Spanish-speaking population-based sample. Assessment. 2017. https:\/\/doi.org\/10.1177\/1073191115602552.","journal-title":"Assessment"},{"key":"10241_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/13825585.2020.1844865","author":"M Belghali","year":"2022","unstructured":"Belghali M, Statsenko Y, Laver V. Stroop switching card test: brief screening of executive functions across the lifespan. Aging Neuropsychol Cogn. 2022. https:\/\/doi.org\/10.1080\/13825585.2020.1844865.","journal-title":"Aging Neuropsychol Cogn"},{"key":"10241_CR47","doi-asserted-by":"publisher","DOI":"10.3758\/s13428-021-01551-3","author":"S Miles","year":"2021","unstructured":"Miles S, Howlett CA, Berryman C, Nedeljkovic M, Moseley GL, Phillipou A. Considerations for using the Wisconsin card sorting test to assess cognitive flexibility. Behav Res Methods. 2021. https:\/\/doi.org\/10.3758\/s13428-021-01551-3.","journal-title":"Behav Res Methods"},{"key":"10241_CR48","doi-asserted-by":"publisher","DOI":"10.1017\/SJP.2021.18","author":"MB Garcia-Martin","year":"2021","unstructured":"Garcia-Martin MB, Ruiz FJ, Bedoya-Valderrama L, Segura-Vargas MA, Pena-Vargas A, Avila-Campos JE, et al. Inhibitory control in individuals with clinical levels of depression and anxiety symptoms. Span J Psychol. 2021. https:\/\/doi.org\/10.1017\/SJP.2021.18.","journal-title":"Span J Psychol"},{"key":"10241_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.03.027","author":"LA Quagliato","year":"2019","unstructured":"Quagliato LA, Freire RC, Nardi AE. Elevated peripheral kynurenine\/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients. J Psychiatr Res. 2019. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.027.","journal-title":"J Psychiatr Res"},{"key":"10241_CR50","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001499","author":"C Fourrier","year":"2019","unstructured":"Fourrier C, Singhal G, Baune BT. Neuroinflammation and cognition across psychiatric conditions. CNS Spectr. 2019. https:\/\/doi.org\/10.1017\/S1092852918001499.","journal-title":"CNS Spectr"},{"key":"10241_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-022-02525-1","author":"M Kucukkarapinar","year":"2022","unstructured":"Kucukkarapinar M, Yay-Pence A, Yildiz Y, Buyukkoruk M, Yaz-Aydin G, Deveci-Bulut TS, et al. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. J Neural Transm. 2022. https:\/\/doi.org\/10.1007\/s00702-022-02525-1.","journal-title":"J Neural Transm"},{"key":"10241_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.02.937","author":"B Fernandes","year":"2021","unstructured":"Fernandes B, Marx W, McGuinness A, Diaz A, Sanches M, Quevedo J, et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a large meta-analysis. Biol Psychiatry. 2021. https:\/\/doi.org\/10.1016\/j.biopsych.2021.02.937.","journal-title":"Biol Psychiatry"},{"key":"10241_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.02.007","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Wurfel BE, Ford BN, Bellgowan PSF, Victor TA, et al. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun. 2015. https:\/\/doi.org\/10.1016\/j.bbi.2015.02.007.","journal-title":"Brain Behav Immun"},{"key":"10241_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00951-9","author":"W Marx","year":"2021","unstructured":"Marx W, McGuinness AJ, Rocks T, Ruusunen A, Cleminson J, Walker AJ, et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41380-020-00951-9.","journal-title":"Mol Psychiatry"},{"key":"10241_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00951-9","author":"H Liu","year":"2018","unstructured":"Liu H, Ding L, Zhang H, Mellor D, Wu H, Zhao D, et al. The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder. Front Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-020-00951-9.","journal-title":"Front Psychiatry"},{"key":"10241_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.07.011","author":"H Zheng","year":"2022","unstructured":"Zheng H, Teague TK, Yeh FC, Burrows K, Figueroa-Hall LK, Aupperle RL, et al. C-reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder. Brain Behav Immun. 2022. https:\/\/doi.org\/10.1016\/j.bbi.2022.07.011.","journal-title":"Brain Behav Immun"},{"key":"10241_CR57","doi-asserted-by":"publisher","DOI":"10.1177\/11786469241245323","author":"F Orhan","year":"2024","unstructured":"Orhan F, Schwieler L, Engberg G, Samuelsson M. Kynurenine metabolites in CSF and plasma in healthy males. Int J Tryptophan Res. 2024. https:\/\/doi.org\/10.1177\/11786469241245323.","journal-title":"Int J Tryptophan Res"},{"key":"10241_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.03.017","author":"M Morrens","year":"2025","unstructured":"Morrens M. The role of the kynurenine pathway in cognitive function in brain disorders: insights and challenges. Brain Behav Immun. 2025. https:\/\/doi.org\/10.1016\/j.bbi.2025.03.017.","journal-title":"Brain Behav Immun"},{"key":"10241_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2024.09.008","author":"J Jasionowska","year":"2024","unstructured":"Jasionowska J, Ga\u0142ecki P, Kalinka E, Skiba A, Szemraj J, Turska E, et al. Level of selected exponents of the kynurenine pathway in patients diagnosed with depression and selected cancers. J Psychiatr Res. 2024. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.008.","journal-title":"J Psychiatr Res"},{"key":"10241_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716980","author":"K Skorobogatov","year":"2021","unstructured":"Skorobogatov K, De Picker L, Verkerk R, Coppens V, Leboyer M, M\u00fcller N, et al. Brain versus blood: a systematic review on the concordance between peripheral and central kynurenine pathway measures in psychiatric disorders. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.716980.","journal-title":"Front Immunol"},{"key":"10241_CR61","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170913110426","author":"YK Kim","year":"2018","unstructured":"Kim YK, Jeon SW. Neuroinflammation and the immune-kynurenine pathway in anxiety disorders. Curr Neuropharmacol. 2018. https:\/\/doi.org\/10.2174\/1570159X15666170913110426.","journal-title":"Curr Neuropharmacol"},{"key":"10241_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.123","author":"EN Wagner","year":"2020","unstructured":"Wagner EN, Strippoli MF, Ajdacic-Gross V, Gholam-Rezaee M, Glaus J, Vandeleur C, et al. Generalized anxiety disorder is prospectively associated with decreased levels of Interleukin-6 and adiponectin among individuals from the community. J Affect Disord. 2020. https:\/\/doi.org\/10.1016\/j.jad.2020.03.123.","journal-title":"J Affect Disord"},{"key":"10241_CR63","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720004389","author":"J Savitz","year":"2022","unstructured":"Savitz J, Ford BN, Yeh HW, Akeman E, Cosgrove K, Clausen AN, et al. Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid. Psychol Med. 2022. https:\/\/doi.org\/10.1017\/S0033291720004389.","journal-title":"Psychol Med"},{"key":"10241_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1380620","author":"EZ Reininghaus","year":"2024","unstructured":"Reininghaus EZ, Lenger M, Sch\u00f6nthaler EMD, Fellendorf FT, Stross T, Schwarz M, et al. Changes in tryptophan breakdown associated with response to multimodal treatment in depression. Front Psychiatry. 2024. https:\/\/doi.org\/10.3389\/fpsyt.2024.1380620.","journal-title":"Front Psychiatry"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-025-10241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11126-025-10241-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-025-10241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:23:46Z","timestamp":1763367826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11126-025-10241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":64,"alternative-id":["10241"],"URL":"https:\/\/doi.org\/10.1007\/s11126-025-10241-8","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflicts of interes\n                      t","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}